Fujitsu forms strategic partnership with Paradigm and will provide offerings that leverage the power of AI
TOKYO, Aug. 26, 2024 /CNW/ -- Fujitsu today announced that it will begin initiatives to attract global clinical trials to Japan and tackle the 'drug loss' issue by working with pharmaceutical companies and medical institutions to build a new medical data ecosystem. The efforts come under the Fujitsu Uvance Healthy Living, which aims to improve people's well-being.
Read more at newswire.ca